ClinConnect ClinConnect Logo
Search / Trial NCT01913132

PICO Above Incisions After Vascular Surgery

Launched by STEFAN ACOSTA · Jul 29, 2013

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Negative Pressure Wound Therapy Vascular Surgery Inguinal Incisions

ClinConnect Summary

The PICO Above Incisions After Vascular Surgery trial is studying whether a special treatment called negative pressure wound therapy can help reduce the risk of infections and other complications in surgical wounds after vascular surgery. Previous studies have shown that infections in the groin area after such surgeries can be quite common, affecting nearly 23% of patients. This trial aims to see if using this therapy on closed incisions can lower that infection rate.

To participate in the trial, you need to be at least 18 years old and scheduled for elective (non-emergency) vascular surgery that involves an incision in the groin area. Participants should be able to understand the study details and provide consent. If you're interested, you can expect to receive close monitoring of your wound after surgery and share your experiences, which could help improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 18 years of age and above
  • Elective vascular surgery
  • Inguinal incision (transverse or longitudinal)
  • Capable of understanding the study information and giving written informed consent
  • Exclusion Criteria:
  • Emergency surgery
  • Ongoing infection in inguinal area

About Stefan Acosta

Stefan Acosta is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and rigorous scientific methodologies, the organization collaborates with leading researchers and institutions to facilitate the development of new treatments across various therapeutic areas. Stefan Acosta prioritizes ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost integrity and respect for participant welfare. Through its strategic partnerships and commitment to excellence, Stefan Acosta aims to contribute significantly to the evolving landscape of healthcare and therapeutic advancements.

Locations

Malmö, , Sweden

Patients applied

0 patients applied

Trial Officials

Stefan Acosta, MD PhD

Principal Investigator

Vascular Centre, Malmö, Skåne University Hospital

Julien Hasselmann, MD

Principal Investigator

Vascular Centre, Malmö, Skåne University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials